A Novel Essential Regulator of Staphylococcus aureus
金黄色葡萄球菌的新型必需调节剂
基本信息
- 批准号:7196421
- 负责人:
- 金额:$ 24.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAnabolismAntibiotic ResistanceAntisense RNABacteriaBacterial PhysiologyBacterial ProteinsCellsCerealsCommunity HospitalsCritical PathwaysDNA-Binding ProteinsDataDoseDown-RegulationEquilibriumGene ExpressionGene TargetingGenesGenomeGoalsGrowthHomologous GeneInfectionIntermediate resistanceLaboratoriesLeadLifeLuciferasesMethicillinMethodsMicroarray AnalysisMolecularMonitorMutagenesisOperonOrganismPathogenesisPhenotypePhosphotransferasesPredispositionPreventivePublic HealthRNA InterferenceRegulationReporterResearchResearch PersonnelSeriesSignal TransductionSkinStaphylococcus aureusStimulusSystemTechnologyTestingTherapeutic AgentsTherapeutic InterventionTimeTranscriptVancomycinVirulenceVirulence Factorsbaseexperienceinhibitor/antagonistinsightmutantnovelpathogenprogramspromoterresponse
项目摘要
DESCRIPTION (provided by applicant): Staphylococcus aureus is a major community and hospital-acquired pathogen causing superficial skin and life-threatening infections worldwide. The continued emergence of multiple-antibiotic resistant strains of S. aureus, especially methicillin and vancomycin-intermediate resistant strains, is of significant public health concern. This organism has evolved into a series of two-component signal transduction systems (TCS) in order to sense its immediate surroundings and to modulate cellular responses and the expression of virulence genes. Our long-term goals are to elucidate the regulatory mechanisms controlling the expression of genes involved in critical pathways in order to identify novel targets for delivering efficacious preventive and/or therapeutic agents against S. aureus. The specific hypothesis is that a novel S. aureus TCS (yhcSR} controls the genes/operons required for bacterial growth. Our hypothesis has been formulated on the basis of our preliminary data that 1) the down-regulation of YhcS (histdine kinase) expression inhibits bacterial growth in a dose-dependent manner; 2) the over-expression of either YhcS or YhcR also impedes bacterial growth; and 3) yhcR encodes a response regulator (DNA-Binding protein) and has many different homologs in various Gram-positive pathogens. Therefore, the objectives of this proposal are to characterize the yhcSR system, identify genes/operons that are controlled by yhcSR, and determine the genes/operons that yhcSR directly regulates, which are required for bacterial survival. We will pursue the following specific aims to test our central hypothesis.
First, we will characterize the yhcSR system to address why it is important for bacterial growth. Second, we will identify the target genes directly regulated by yhcSR and determine the importance of the identified gene products for bacterial growth. Third, we will determine what controls yhcSR expression. These results will not only provide new insights into the regulatory mechanisms of bacterial physiology, but may also lead to the identification of novel targets for developing preventive and therapeutic interventions.
描述(由申请方提供):金黄色葡萄球菌是一种主要的社区和医院获得性病原体,在全球范围内引起浅表皮肤和危及生命的感染。多重耐药菌株的不断出现是导致耐药的主要原因。金黄色葡萄球菌,特别是甲氧西林和万古霉素中间体抗性菌株,是重要的公共卫生问题。这种生物体已经进化成一系列的双组分信号转导系统(TCS),以感受其周围环境,并调节细胞反应和毒力基因的表达。我们的长期目标是阐明控制关键途径中所涉及的基因表达的调控机制,以确定用于提供有效的预防和/或治疗药物的新靶点。金黄色。具体的假设是,一个新的S。金黄色葡萄球菌TCS(yhcSR)控制细菌生长所需的基因/操纵子。我们的假设是基于我们的初步数据,即1)YhcS(组氨酸激酶)表达的下调以剂量依赖性方式抑制细菌生长; 2)YhcS或YhcR的过度表达也阻碍细菌生长; 3)yhcR编码反应调节因子(DNA结合蛋白),并在各种革兰氏阳性病原体中具有许多不同的同源物。因此,本提案的目的是表征yhcSR系统,鉴定由yhcSR控制的基因/操纵子,并确定yhcSR直接调节的基因/操纵子,这些基因/操纵子是细菌存活所需的。我们将追求以下具体目标来检验我们的中心假设。
首先,我们将描述yhcSR系统,以解决为什么它对细菌生长很重要。其次,我们将确定直接调控的目标基因yhcSR和确定的基因产物的细菌生长的重要性。第三,我们将确定是什么控制yhcSR表达。这些结果不仅将为细菌生理学的调控机制提供新的见解,而且还可能导致开发预防和治疗干预措施的新靶点的确定。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yinduo Ji其他文献
Yinduo Ji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yinduo Ji', 18)}}的其他基金
Biomarker Screening of Essential Putative Glycoprotease Inhibitor
必需的假定糖蛋白酶抑制剂的生物标志物筛选
- 批准号:
8071522 - 财政年份:2010
- 资助金额:
$ 24.81万 - 项目类别:
Biomarker Screening of Essential Putative Glycoprotease Inhibitor
必需的假定糖蛋白酶抑制剂的生物标志物筛选
- 批准号:
7779870 - 财政年份:2010
- 资助金额:
$ 24.81万 - 项目类别:
Biomarker Screening of Essential Putative Glycoprotease Inhibitor
必需的假定糖蛋白酶抑制剂的生物标志物筛选
- 批准号:
8259532 - 财政年份:2010
- 资助金额:
$ 24.81万 - 项目类别:
Novel antibacterial target: an essential glycoprotease
新型抗菌靶点:必需的糖蛋白酶
- 批准号:
7097649 - 财政年份:2006
- 资助金额:
$ 24.81万 - 项目类别:
Novel antibacterial target: an essential glycoprotease
新型抗菌靶点:必需的糖蛋白酶
- 批准号:
7230236 - 财政年份:2006
- 资助金额:
$ 24.81万 - 项目类别:
A Novel Essential Regulator of Staphylococcus aureus
金黄色葡萄球菌的新型必需调节剂
- 批准号:
7069489 - 财政年份:2005
- 资助金额:
$ 24.81万 - 项目类别:
A Novel Essential Regulator of Staphylococcus aureus
金黄色葡萄球菌的新型必需调节剂
- 批准号:
6968033 - 财政年份:2005
- 资助金额:
$ 24.81万 - 项目类别:
A Novel Essential Regulator of Staphylococcus aureus
金黄色葡萄球菌的新型必需调节剂
- 批准号:
7369903 - 财政年份:2005
- 资助金额:
$ 24.81万 - 项目类别:
相似海外基金
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10590611 - 财政年份:2022
- 资助金额:
$ 24.81万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中的骨-脂肪相互作用
- 批准号:
10706006 - 财政年份:2022
- 资助金额:
$ 24.81万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10368975 - 财政年份:2021
- 资助金额:
$ 24.81万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10365254 - 财政年份:2021
- 资助金额:
$ 24.81万 - 项目类别:
Bone-Adipose Interactions During Skeletal Anabolism
骨骼合成代谢过程中骨-脂肪相互作用
- 批准号:
10202896 - 财政年份:2021
- 资助金额:
$ 24.81万 - 项目类别:
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Combined long-acting PTH and calcimimetics actions on skeletal anabolism
BCCMA:针对和抵抗不利于骨骼的条件的基础研究(遏制骨折):长效 PTH 和拟钙剂联合作用对骨骼合成代谢的作用
- 批准号:
10531570 - 财政年份:2021
- 资助金额:
$ 24.81万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10541847 - 财政年份:2019
- 资助金额:
$ 24.81万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10319573 - 财政年份:2019
- 资助金额:
$ 24.81万 - 项目类别:
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
剖析与年龄和骨关节炎相关的关节软骨合成代谢下降有关的分子机制
- 批准号:
10062790 - 财政年份:2019
- 资助金额:
$ 24.81万 - 项目类别:
Promotion of NAD+ anabolism to promote lifespan
促进NAD合成代谢以延长寿命
- 批准号:
DE170100628 - 财政年份:2017
- 资助金额:
$ 24.81万 - 项目类别:
Discovery Early Career Researcher Award














{{item.name}}会员




